Edgar Mugema Mulogo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Edgar Mugema Mulogo has a total of 204 co-authors. Here are the top co-authors by number of shared publications:
- Ross M. Boyce
Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina
9 shared publications Moses Ntaro
Department of Community Health, Mbarara University of Science and Technology, Mbarara, UGA
8 shared publicationsMichael Matte
Department of Community Health, Mbarara University of Science and Technology, Mbarara, UGA
6 shared publications- Moses Ntaro
Department of Community Health, Mbarara University of Science and Technology, Mbarara, Uganda
6 shared publications Andrew Wesuta
Department of Community Health Mbarara University of Science and Technology Mbarara UGA
5 shared publications- Benson Musinguzi
Department of Medical Laboratory Sciences, Faculty of Health Sciences, Muni University, Arua, Uganda
4 shared publications
Latest Publications
- Open Access
- 14 June 2026
- Published by Springer Nature in Cureus
- Vol. 18 (6)
Timeliness of Care-Seeking From Village Health Workers for Children Under Five Years During the COVID-19 Lockdown in Southwestern Uganda
- 14 June 2026
- Published by Springer Nature in Cureus
- Vol. 18 (6)
Open AccessTimeliness of Care-Seeking From Village Health Workers for Children Under Five Years During the COVID-19 Lockdown in Southwestern Uganda
- Open Access
- 1 June 2026
- Published by Microbiology Society in Access Microbiology
- Vol. 8 (6)
Burden of extended-spectrum beta-lactamase-producing Enterobacteriaceae among cancer patients in Africa: a systematic review and meta-analysis
Background. Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-P E ) exacerbate infections in cancer patients in settings where antimicrobial resistance threatens health outcomes. This study estimated the prevalence of ESBL-P E among cancer patients in Africa from 1 January 2010 to 31 December 2024. Methods. We searched PubMed, Embase, Web of Science, CINAHL and Global Health for observational studies reporting ESBL-P E prevalence in cancer patients. Studies published in English from 1 January 2010 to 31 December 2024 were included. Two reviewers independently screened studies, extracted data using standardized forms and assessed the quality of articles using the Newcastle–Ottawa Scale. Pooled prevalence was calculated using a random-effects model in RStudio v4.4.2, with heterogeneity assessed with the I ² statistic and publication bias assessed with funnel plots and Egger’s test. Results. Twelve studies from 9 African countries, involving a total of 1,252 cancer patients and 643 identified events, were included. The pooled prevalence of ESBL-P E was 49.4% (95% CI: 36.0–62.9%, I ²=88.3%, P Escherichia coli and Klebsiella pneumoniae predominated. There was no evidence of publication bias based on funnel plot symmetry, Egger’s test ( t =−0.35, P =0.73) and trim-and-fill analysis (no studies imputed; adjusted estimate unchanged). Heterogeneity was substantial ( I ²=88.3%) with a wide 95% prediction interval (22.7–76.5%). Leave-one-out sensitivity analysis confirmed estimate stability (~49%) with persistently high heterogeneity ( I ² range: 81.4–89.4%). Conclusions. The high ESBL-P E prevalence in African cancer patients signals a critical public health issue, necessitating enhanced surveillance, antimicrobial stewardship and intentional infection control measures.
- 1 June 2026
- Published by Microbiology Society in Access Microbiology
- Vol. 8 (6)
Open AccessBurden of extended-spectrum beta-lactamase-producing Enterobacteriaceae among cancer patients in Africa: a systematic review and meta-analysis
Background. Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-P E ) exacerbate infections in cancer patients in settings where antimicrobial resistance threatens health outcomes. This study estimated the prevalence of ESBL-P E among cancer patients in Africa from 1 January 2010 to 31 December 2024. Methods. We searched PubMed, Embase, Web of Science, CINAHL and Global Health for observational studies reporting ESBL-P E prevalence in cancer patients. Studies published in English from 1 January 2010 to 31 December 2024 were included. Two reviewers independently screened studies, extracted data using standardized forms and assessed the quality of articles using the Newcastle–Ottawa Scale. Pooled prevalence was calculated using a random-effects model in RStudio v4.4.2, with heterogeneity assessed with the I ² statistic and publication bias assessed with funnel plots and Egger’s test. Results. Twelve studies from 9 African countries, involving a total of 1,252 cancer patients and 643 identified events, were included. The pooled prevalence of ESBL-P E was 49.4% (95% CI: 36.0–62.9%, I ²=88.3%, P Escherichia coli and Klebsiella pneumoniae predominated. There was no evidence of publication bias based on funnel plot symmetry, Egger’s test ( t =−0.35, P =0.73) and trim-and-fill analysis (no studies imputed; adjusted estimate unchanged). Heterogeneity was substantial ( I ²=88.3%) with a wide 95% prediction interval (22.7–76.5%). Leave-one-out sensitivity analysis confirmed estimate stability (~49%) with persistently high heterogeneity ( I ² range: 81.4–89.4%). Conclusions. The high ESBL-P E prevalence in African cancer patients signals a critical public health issue, necessitating enhanced surveillance, antimicrobial stewardship and intentional infection control measures.
- Open Access
- 30 March 2026
- Published by Springer Nature in Cureus
- Vol. 18 (3) , e106097
Willingness to Use a Mobile Application for Scheduling Consultation Appointments Among Patients, Caregivers, and Healthcare Providers in Southwestern Uganda
Background Mobile applications are increasingly used to support healthcare delivery in Uganda. MobiCare is a mobile application developed to facilitate the scheduling of patient appointments at health facilities. This study assessed the willingness of patients/caregivers and healthcare providers to use the MobiCare application in private health facilities in Mbarara Municipality, Uganda. Methods A cross-sectional survey was conducted between July and September 2019 in five private hospitals in Mbarara Municipality. Structured interviewer-administered questionnaires were used to collect data from 97 patients/caregivers and 32 healthcare providers. Descriptive statistics were used to summarize findings, and inferential analysis was conducted among healthcare providers. Results All patients/caregivers owned a smartphone and reported internet use (97/97; 100.0%), and nearly all had previously used a mobile application (96/97; 99.0%). Awareness of mobile applications linking patients to healthcare providers was low (8/97; 8.2%). Willingness to use MobiCare was high among patients/caregivers (97/97; 100.0%) and healthcare providers (31/32; 96.9%). Most patients/caregivers recommended the application for scheduling appointments for children under five years (92/97; 94.8%). Among healthcare providers, dissatisfaction with existing appointment scheduling systems was associated with willingness to use MobiCare (OR = 3.7, 95% CI: 1.2-11.4; p = 0.02). Conclusion Willingness to use the MobiCare application was high among patients/caregivers and healthcare providers in private health facilities in Mbarara Municipality. Widespread smartphone ownership and internet use, together with dissatisfaction with existing appointment systems among providers, suggest favorable conditions for introducing digital appointment-scheduling tools in urban private healthcare settings. Further implementation research is needed to assess real-world uptake, usability, and impact on service delivery.
- 30 March 2026
- Published by Springer Nature in Cureus
- Vol. 18 (3) , e106097
Open AccessWillingness to Use a Mobile Application for Scheduling Consultation Appointments Among Patients, Caregivers, and Healthcare Providers in Southwestern Uganda
Background Mobile applications are increasingly used to support healthcare delivery in Uganda. MobiCare is a mobile application developed to facilitate the scheduling of patient appointments at health facilities. This study assessed the willingness of patients/caregivers and healthcare providers to use the MobiCare application in private health facilities in Mbarara Municipality, Uganda. Methods A cross-sectional survey was conducted between July and September 2019 in five private hospitals in Mbarara Municipality. Structured interviewer-administered questionnaires were used to collect data from 97 patients/caregivers and 32 healthcare providers. Descriptive statistics were used to summarize findings, and inferential analysis was conducted among healthcare providers. Results All patients/caregivers owned a smartphone and reported internet use (97/97; 100.0%), and nearly all had previously used a mobile application (96/97; 99.0%). Awareness of mobile applications linking patients to healthcare providers was low (8/97; 8.2%). Willingness to use MobiCare was high among patients/caregivers (97/97; 100.0%) and healthcare providers (31/32; 96.9%). Most patients/caregivers recommended the application for scheduling appointments for children under five years (92/97; 94.8%). Among healthcare providers, dissatisfaction with existing appointment scheduling systems was associated with willingness to use MobiCare (OR = 3.7, 95% CI: 1.2-11.4; p = 0.02). Conclusion Willingness to use the MobiCare application was high among patients/caregivers and healthcare providers in private health facilities in Mbarara Municipality. Widespread smartphone ownership and internet use, together with dissatisfaction with existing appointment systems among providers, suggest favorable conditions for introducing digital appointment-scheduling tools in urban private healthcare settings. Further implementation research is needed to assess real-world uptake, usability, and impact on service delivery.
- Open Access
- 23 February 2026
- Published by Microbiology Society
- p. 001120.v3
Burden of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae among Cancer Patients in Africa: A Systematic Review and Meta-Analysis
Background : Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) exacerbate infections in cancer patients, in settings where antimicrobial resistance threatens health outcomes. This study estimated the prevalence of ESBL-PE among cancer patients in Africa from 2010 to 2024. Methods: We searched PubMed, Embase, Web of Science, CINAHL, and Global Health for observational studies reporting ESBL-PE prevalence in cancer patients. Studies published in English from 2010 to 2024 were included. Two reviewers independently screened studies, extracted data using standardized forms, and assessed quality using the Newcastle-Ottawa Scale. Pooled prevalence was calculated using a random-effects model in RStudio v4.4.2, with heterogeneity assessed by I² statistics and publication bias by funnel plots and Egger’s test. Results: Twelve studies from nine African countries, involving 565 patients (305 events) and 687 samples (338 events), were included. The pooled prevalence was 49.9% (95% CI: 23.1%-76.9%, I² = 91.8%, p < 0.001) at the patient level and 48.1% (95% CI: 31.7%-65.0%, I² = 84.0%, p < 0.001) at the sample level. Escherichia coli and Klebsiella pneumoniae predominated, with high resistance to cephalosporins (median: 89.5%-90%) and fluoroquinolones but preserved carbapenem efficacy. Publication bias was evident, and heterogeneity persisted after sensitivity analysis. Conclusions: The high ESBL-PE prevalence in African cancer patients signals a critical public health issue, necessitating enhanced surveillance, antimicrobial stewardship, and intentional infection control measures.
- 23 February 2026
- Published by Microbiology Society
- p. 001120.v3
Open AccessBurden of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae among Cancer Patients in Africa: A Systematic Review and Meta-Analysis
Background : Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) exacerbate infections in cancer patients, in settings where antimicrobial resistance threatens health outcomes. This study estimated the prevalence of ESBL-PE among cancer patients in Africa from 2010 to 2024. Methods: We searched PubMed, Embase, Web of Science, CINAHL, and Global Health for observational studies reporting ESBL-PE prevalence in cancer patients. Studies published in English from 2010 to 2024 were included. Two reviewers independently screened studies, extracted data using standardized forms, and assessed quality using the Newcastle-Ottawa Scale. Pooled prevalence was calculated using a random-effects model in RStudio v4.4.2, with heterogeneity assessed by I² statistics and publication bias by funnel plots and Egger’s test. Results: Twelve studies from nine African countries, involving 565 patients (305 events) and 687 samples (338 events), were included. The pooled prevalence was 49.9% (95% CI: 23.1%-76.9%, I² = 91.8%, p < 0.001) at the patient level and 48.1% (95% CI: 31.7%-65.0%, I² = 84.0%, p < 0.001) at the sample level. Escherichia coli and Klebsiella pneumoniae predominated, with high resistance to cephalosporins (median: 89.5%-90%) and fluoroquinolones but preserved carbapenem efficacy. Publication bias was evident, and heterogeneity persisted after sensitivity analysis. Conclusions: The high ESBL-PE prevalence in African cancer patients signals a critical public health issue, necessitating enhanced surveillance, antimicrobial stewardship, and intentional infection control measures.
- 10 February 2026
- Published by Wolters Kluwer Health in JBI Evidence Synthesis
- Vol. 24 (2) , 342-348
Identification and mapping of mHealth interventions applied in palliative care in sub-Saharan Africa: a scoping review protocol
Objective: The aim of this scoping review is to identify the currently available mHealth interventions for palliative care and factors influencing their use in sub-Saharan Africa (SSA). Introduction: Although palliative care is essential for improving quality of life, its use in SSA remains low. mHealth (an interaction with a mobile device) interventions could enhance and promote palliative care in the region. Integration of mHealth into palliative care has been observed across Europe and the USA to support pain management and improve communication between health professionals and patients; however, there is little evidence on its use in low- and middle-income countries. Eligibility criteria: Eligible studies will involve key stakeholders in palliative care, such as patients with life-limiting illnesses (eg, cancer), health professionals, community volunteer workers, and community leaders. Studies reporting evidence on mHealth in the design, implementation, or evaluation of palliative care services in any country in SSA will be considered. Methods: The review will follow JBI methodology for scoping reviews and will be reported using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). The following sources will be searched for published and unpublished literature: CINAHL (EBSCOhost), PubMed (Ovid), Embase (Ovid), the Cochrane Library, Google Scholar, Scopus, Web of Science, and ProQuest Dissertations and Theses Global. Study screening and selection will be conducted independently by 2 reviewers. Data will be extracted using a modified JBI data charting form, and will be presented in tabular format and narrative summary. Review registration: OSF https://osf.io/gbqcn/overview
- 10 February 2026
- Published by Wolters Kluwer Health in JBI Evidence Synthesis
- Vol. 24 (2) , 342-348
Identification and mapping of mHealth interventions applied in palliative care in sub-Saharan Africa: a scoping review protocol
Objective: The aim of this scoping review is to identify the currently available mHealth interventions for palliative care and factors influencing their use in sub-Saharan Africa (SSA). Introduction: Although palliative care is essential for improving quality of life, its use in SSA remains low. mHealth (an interaction with a mobile device) interventions could enhance and promote palliative care in the region. Integration of mHealth into palliative care has been observed across Europe and the USA to support pain management and improve communication between health professionals and patients; however, there is little evidence on its use in low- and middle-income countries. Eligibility criteria: Eligible studies will involve key stakeholders in palliative care, such as patients with life-limiting illnesses (eg, cancer), health professionals, community volunteer workers, and community leaders. Studies reporting evidence on mHealth in the design, implementation, or evaluation of palliative care services in any country in SSA will be considered. Methods: The review will follow JBI methodology for scoping reviews and will be reported using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). The following sources will be searched for published and unpublished literature: CINAHL (EBSCOhost), PubMed (Ovid), Embase (Ovid), the Cochrane Library, Google Scholar, Scopus, Web of Science, and ProQuest Dissertations and Theses Global. Study screening and selection will be conducted independently by 2 reviewers. Data will be extracted using a modified JBI data charting form, and will be presented in tabular format and narrative summary. Review registration: OSF https://osf.io/gbqcn/overview
- Open Access
- 9 February 2026
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 120 (7) , 723-731
Extreme weather effects on health services and communities in low and lower-middle income countries: a thematic systematic review
Most previous research about the dangers of extreme weather events was applicable to populations in high-income countries. Data summarising harms related to extreme weather events in low-income settings are lacking. A systematic review thematically summarising evidence about weather event-linked harms and responses in low- and lower-middle-income countries was conducted. Peer-reviewed and grey literature was systematically searched and selected. Data were extracted about harms, responses and outcomes relevant to six WHO building blocks of healthcare systems. Framework analysis was used to identify predominant themes related to harms, responses and the WHO building blocks. In total, 183 reports were included. Flooding and high winds were the most common types of extreme weather events documented. The main community experience themes identified were the displacement of populations and disruption. The main themes identified for health service delivery were vulnerability, disruption and resilience. Documented examples of resilience or recovery were far fewer for all six WHO healthcare system building blocks than descriptions of vulnerability and disruption. Extreme weather events can be highly disruptive and harmful to healthcare systems and communities in LMIC settings that are often already highly vulnerable.
- 9 February 2026
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 120 (7) , 723-731
Open AccessExtreme weather effects on health services and communities in low and lower-middle income countries: a thematic systematic review
Most previous research about the dangers of extreme weather events was applicable to populations in high-income countries. Data summarising harms related to extreme weather events in low-income settings are lacking. A systematic review thematically summarising evidence about weather event-linked harms and responses in low- and lower-middle-income countries was conducted. Peer-reviewed and grey literature was systematically searched and selected. Data were extracted about harms, responses and outcomes relevant to six WHO building blocks of healthcare systems. Framework analysis was used to identify predominant themes related to harms, responses and the WHO building blocks. In total, 183 reports were included. Flooding and high winds were the most common types of extreme weather events documented. The main community experience themes identified were the displacement of populations and disruption. The main themes identified for health service delivery were vulnerability, disruption and resilience. Documented examples of resilience or recovery were far fewer for all six WHO healthcare system building blocks than descriptions of vulnerability and disruption. Extreme weather events can be highly disruptive and harmful to healthcare systems and communities in LMIC settings that are often already highly vulnerable.
- Open Access
- 21 January 2026
- Published by Springer Nature in Cureus
- Vol. 18 (1)
Primary Care Providers’ Perspectives of Knowledge and Skill Acquisition, and Benefits Following University Faculty-Led Continuing Medical Education Sessions: Results of a Qualitative Assessment in Southwest Uganda
Background and objective Mbarara University of Science and Technology's (MUST) First Mile Community Health Program (FMCH) has been at the forefront of providing continuing medical education (CME) to primary care providers working in health facilities in southwestern Uganda. However, little is known about how CME has influenced primary care providers' knowledge and skills. This qualitative assessment sought to describe participants' perspectives on knowledge and skill acquisition following these CME sessions. Methods In 2024, a descriptive review was carried out using activity reports from CME sessions. The review included CME sessions conducted over two years (2018-2019). Forty primary care providers from 40 health facilities, ranging from health centers (HCs) to general hospitals, participated in each CME session offered by MUST faculty. CME sessions were provided in the following areas: basic emergency obstetric care (BEmOC), emergency triage, assessment, and treatment, admission care for the sick child and newborn (ETAT+), and infection prevention and control. Results Primary care providers reported gains in knowledge and skills as well as other benefits after attending CME sessions, particularly in newborn care, the manual vacuum aspiration (MVA) procedure, management of preeclampsia, birth monitoring, and infection prevention and control. The average pre-test score was 58%, while the average post-test score was 80%. The percentage change in knowledge was 22%. The providers reported incorporating previously overlooked skills or procedures into their clinical practice. Conclusions University-led CME sessions can be an effective method for primary care providers working in resourcelimited settings to acquire knowledge and enhance their skills. Fostering partnerships between universities and stakeholders in the local health system to support the sustainability of CMEs is likely to have a positive impact on healthcare delivery.
- 21 January 2026
- Published by Springer Nature in Cureus
- Vol. 18 (1)
Open AccessPrimary Care Providers’ Perspectives of Knowledge and Skill Acquisition, and Benefits Following University Faculty-Led Continuing Medical Education Sessions: Results of a Qualitative Assessment in Southwest Uganda
Background and objective Mbarara University of Science and Technology's (MUST) First Mile Community Health Program (FMCH) has been at the forefront of providing continuing medical education (CME) to primary care providers working in health facilities in southwestern Uganda. However, little is known about how CME has influenced primary care providers' knowledge and skills. This qualitative assessment sought to describe participants' perspectives on knowledge and skill acquisition following these CME sessions. Methods In 2024, a descriptive review was carried out using activity reports from CME sessions. The review included CME sessions conducted over two years (2018-2019). Forty primary care providers from 40 health facilities, ranging from health centers (HCs) to general hospitals, participated in each CME session offered by MUST faculty. CME sessions were provided in the following areas: basic emergency obstetric care (BEmOC), emergency triage, assessment, and treatment, admission care for the sick child and newborn (ETAT+), and infection prevention and control. Results Primary care providers reported gains in knowledge and skills as well as other benefits after attending CME sessions, particularly in newborn care, the manual vacuum aspiration (MVA) procedure, management of preeclampsia, birth monitoring, and infection prevention and control. The average pre-test score was 58%, while the average post-test score was 80%. The percentage change in knowledge was 22%. The providers reported incorporating previously overlooked skills or procedures into their clinical practice. Conclusions University-led CME sessions can be an effective method for primary care providers working in resourcelimited settings to acquire knowledge and enhance their skills. Fostering partnerships between universities and stakeholders in the local health system to support the sustainability of CMEs is likely to have a positive impact on healthcare delivery.
- Open Access
- 10 November 2025
- Published by Microbiology Society
- p. 001120.v2
Burden of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae among Cancer Patients in Africa: A Systematic Review and Meta-Analysis
Background : Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) exacerbate infections in cancer patients, in settings where antimicrobial resistance threatens health outcomes. This study estimated the prevalence of ESBL-PE among cancer patients in Africa from 2010 to 2024. Methods: We searched PubMed, Embase, Web of Science, CINAHL, and Global Health for observational studies reporting ESBL-PE prevalence in cancer patients. Studies published in English from 2010 to 2024 were included. Two reviewers independently screened studies, extracted data using standardized forms, and assessed quality using the Newcastle-Ottawa Scale. Pooled prevalence was calculated using a random-effects model in RStudio v4.4.2, with heterogeneity assessed by I² statistics and publication bias by funnel plots and Egger’s test. Results: Twelve studies from nine African countries, involving 565 patients (305 events) and 687 samples (338 events), were included. The pooled prevalence was 49.9% (95% CI: 23.1%-76.9%, I² = 91.8%, p < 0.001) at the patient level and 48.1% (95% CI: 31.7%-65.0%, I² = 84.0%, p < 0.001) at the sample level. Escherichia coli and Klebsiella pneumoniae predominated, with high resistance to cephalosporins (median: 89.5%-90%) and fluoroquinolones but preserved carbapenem efficacy. Publication bias was evident, and heterogeneity persisted after sensitivity analysis. Conclusions: The high ESBL-PE prevalence in African cancer patients signals a critical public health issue, necessitating enhanced surveillance, antimicrobial stewardship, and intentional infection control measures.
- 10 November 2025
- Published by Microbiology Society
- p. 001120.v2
Open AccessBurden of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae among Cancer Patients in Africa: A Systematic Review and Meta-Analysis
Background : Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) exacerbate infections in cancer patients, in settings where antimicrobial resistance threatens health outcomes. This study estimated the prevalence of ESBL-PE among cancer patients in Africa from 2010 to 2024. Methods: We searched PubMed, Embase, Web of Science, CINAHL, and Global Health for observational studies reporting ESBL-PE prevalence in cancer patients. Studies published in English from 2010 to 2024 were included. Two reviewers independently screened studies, extracted data using standardized forms, and assessed quality using the Newcastle-Ottawa Scale. Pooled prevalence was calculated using a random-effects model in RStudio v4.4.2, with heterogeneity assessed by I² statistics and publication bias by funnel plots and Egger’s test. Results: Twelve studies from nine African countries, involving 565 patients (305 events) and 687 samples (338 events), were included. The pooled prevalence was 49.9% (95% CI: 23.1%-76.9%, I² = 91.8%, p < 0.001) at the patient level and 48.1% (95% CI: 31.7%-65.0%, I² = 84.0%, p < 0.001) at the sample level. Escherichia coli and Klebsiella pneumoniae predominated, with high resistance to cephalosporins (median: 89.5%-90%) and fluoroquinolones but preserved carbapenem efficacy. Publication bias was evident, and heterogeneity persisted after sensitivity analysis. Conclusions: The high ESBL-PE prevalence in African cancer patients signals a critical public health issue, necessitating enhanced surveillance, antimicrobial stewardship, and intentional infection control measures.
- Open Access
- 30 October 2025
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5 (10) , e0004949
Beyond facility-based births: Is Uganda delivering effective maternal and newborn care? An analysis of the 2022 demographic health survey and 2023 harmonized health facility assessment survey
Maternal and newborn studies in Uganda have primarily focused on measuring contact coverage, such as the proportion of facility-based births. However, this is inadequate and may overestimate the benefits of services provided to women and newborns if the quality of care in the facilities is not considered. Effective coverage of care addresses this limitation and adjusts for the quality of services. This study assessed the effective coverage of maternal and newborn care for facility-based births in Uganda using the 2022 Uganda Demographic and Health Survey (DHS) and the 2023 Harmonized Health Facility Assessment (HHFA). The analysis included 5,618 women who had a live birth in the two years preceding the DHS, and 636 facilities providing childbirth care from the HHFA. Facility readiness was assessed using four domains: human resources, equipment, amenities, and drugs and supplies. Crude coverage was calculated as the percentage of facility births. Two measures of effective coverage were estimated: intervention coverage as a percentage of women who received all ten selected recommended interventions for their most recent birth, and readiness-adjusted coverage as a product of crude coverage and facility readiness using an ecological linking method by region. 85.9% of the women gave birth in a facility, but only 14.0% received all ten interventions. Readiness was highest in government hospitals (81.9%) and lowest in lower government health centers (46.4%). Only 47.8% of women gave birth in a ready facility. Readiness-adjusted coverage varied across regions, with the lowest in Kampala (40.9%) and the highest in the North-Eastern (61.4%). These Findings indicate a large gap between crude and effective coverage, disproportionately affecting regions and lower-level health centers, highlighting a need to enhance the capacity of lower-level health centers to deliver quality maternal and newborn care.
- 30 October 2025
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5 (10) , e0004949
Open AccessBeyond facility-based births: Is Uganda delivering effective maternal and newborn care? An analysis of the 2022 demographic health survey and 2023 harmonized health facility assessment survey
Maternal and newborn studies in Uganda have primarily focused on measuring contact coverage, such as the proportion of facility-based births. However, this is inadequate and may overestimate the benefits of services provided to women and newborns if the quality of care in the facilities is not considered. Effective coverage of care addresses this limitation and adjusts for the quality of services. This study assessed the effective coverage of maternal and newborn care for facility-based births in Uganda using the 2022 Uganda Demographic and Health Survey (DHS) and the 2023 Harmonized Health Facility Assessment (HHFA). The analysis included 5,618 women who had a live birth in the two years preceding the DHS, and 636 facilities providing childbirth care from the HHFA. Facility readiness was assessed using four domains: human resources, equipment, amenities, and drugs and supplies. Crude coverage was calculated as the percentage of facility births. Two measures of effective coverage were estimated: intervention coverage as a percentage of women who received all ten selected recommended interventions for their most recent birth, and readiness-adjusted coverage as a product of crude coverage and facility readiness using an ecological linking method by region. 85.9% of the women gave birth in a facility, but only 14.0% received all ten interventions. Readiness was highest in government hospitals (81.9%) and lowest in lower government health centers (46.4%). Only 47.8% of women gave birth in a ready facility. Readiness-adjusted coverage varied across regions, with the lowest in Kampala (40.9%) and the highest in the North-Eastern (61.4%). These Findings indicate a large gap between crude and effective coverage, disproportionately affecting regions and lower-level health centers, highlighting a need to enhance the capacity of lower-level health centers to deliver quality maternal and newborn care.
- Open Access
- 30 September 2025
- Published by Microbiology Society
- p. 001120.v1
Burden of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae among Cancer Patients in Africa: A Systematic Review and Meta-Analysis
Background : Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) exacerbate infections in cancer patients, in settings where antimicrobial resistance threatens health outcomes. This study estimated the prevalence of ESBL-PE among cancer patients in Africa from 2010 to 2024. Methods: We searched PubMed, Embase, Web of Science, CINAHL, and Global Health for observational studies reporting ESBL-PE prevalence in cancer patients. Studies published in English from 2010 to 2024 were included. Two reviewers independently screened studies, extracted data using standardized forms, and assessed quality using the Newcastle-Ottawa Scale. Pooled prevalence was calculated using a random-effects model in RStudio v4.4.2, with heterogeneity assessed by I² statistics and publication bias by funnel plots and Egger’s test. Results: Twelve studies from nine African countries, involving 565 patients (305 events) and 687 samples (338 events), were included. The pooled prevalence was 49.9% (95% CI: 23.1%-76.9%, I² = 91.8%, p < 0.001) at the patient level and 48.1% (95% CI: 31.7%-65.0%, I² = 84.0%, p < 0.001) at the sample level. Escherichia coli and Klebsiella pneumoniae predominated, with high resistance to cephalosporins (median: 89.5%-90%) and fluoroquinolones but preserved carbapenem efficacy. Publication bias was evident, and heterogeneity persisted after sensitivity analysis. Conclusions: The high ESBL-PE prevalence in African cancer patients signals a critical public health issue, necessitating enhanced surveillance, antimicrobial stewardship, and intentional infection control measures.
- 30 September 2025
- Published by Microbiology Society
- p. 001120.v1
Open AccessBurden of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae among Cancer Patients in Africa: A Systematic Review and Meta-Analysis
Background : Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) exacerbate infections in cancer patients, in settings where antimicrobial resistance threatens health outcomes. This study estimated the prevalence of ESBL-PE among cancer patients in Africa from 2010 to 2024. Methods: We searched PubMed, Embase, Web of Science, CINAHL, and Global Health for observational studies reporting ESBL-PE prevalence in cancer patients. Studies published in English from 2010 to 2024 were included. Two reviewers independently screened studies, extracted data using standardized forms, and assessed quality using the Newcastle-Ottawa Scale. Pooled prevalence was calculated using a random-effects model in RStudio v4.4.2, with heterogeneity assessed by I² statistics and publication bias by funnel plots and Egger’s test. Results: Twelve studies from nine African countries, involving 565 patients (305 events) and 687 samples (338 events), were included. The pooled prevalence was 49.9% (95% CI: 23.1%-76.9%, I² = 91.8%, p < 0.001) at the patient level and 48.1% (95% CI: 31.7%-65.0%, I² = 84.0%, p < 0.001) at the sample level. Escherichia coli and Klebsiella pneumoniae predominated, with high resistance to cephalosporins (median: 89.5%-90%) and fluoroquinolones but preserved carbapenem efficacy. Publication bias was evident, and heterogeneity persisted after sensitivity analysis. Conclusions: The high ESBL-PE prevalence in African cancer patients signals a critical public health issue, necessitating enhanced surveillance, antimicrobial stewardship, and intentional infection control measures.